Product Details
Product Name:
AA147 |
CAS No.:
393121-74-9 |
Purity:
99.24% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | AA147 |
Description | AA147 (ATF6-activator-147) is a small molecule endoplasmic reticulum (ER) proteostasis regulator. The selectively activates ATF6 arm of the unfolded protein response (UPR) .It acts as a prodrug that preferentially triggers ATF6 signaling through a mechanism involving localized metabolic activation and selective covalent modification of ER resident proteins that regulate ATF6 activity. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 25 mg/mL (97.92 mM)
|
Keywords | neurodegenerative disorders | SMA | ATF6 | BPAEC | NRF2 | AA-147 | Inhibitor | AA 147 | inhibit | ROS | AA147 |
Related Compound Libraries | Bioactive Compound Library | Endoplasmic Reticulum Stress Compound Library | NO PAINS Compound Library | Bioactive Compounds Library Max | Transcription Factor-Targeted Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:17817-31-1
$188.00 / 1mg
-
CAS:10141-51-2
$42.00 / 1mg
-
CAS:1383816-29-2
$89.00 / 1mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$57.00/5mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-19 |